Health Services Research & Pharmacoepi Unit

Name

Health Services Research & Pharmacoepi Unit

Legal name

Fundació per al Foment de la Investigació Sanitària i Biomèdica a la Comunitat Valenciana (Fisabio)

Website

https://grupos.fisabio.san.gva.es

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Public Health Research

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

akta.pro secondary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

• Pharmacoepidemiology research
• Public health research
• Biomedical research services
• Health services research
• Clinical trials management

Headquarters

HQ city

Valencia

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Revenue model

1. Public Institutional Funding: The unit operates as part of Fundació Fisabio, funded through the Generalitat Valenciana (Conselleria de Sanitat), European Regional Development Fund (ERDF) grants, PRTR NextGenEU funding, and other public research financing mechanisms.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

The Health Services Research & Pharmacoepi Unit conducts pharmacoepidemiology, health services research, and public health research for the Valencian Community public health system. Operating as a research group within Fundació Fisabio, it contributes to clinical trial management, scientific publishing, and technology transfer initiatives funded through public research grants.

Product overview

The source data pertains to FISABIO (Fundació Fisabio), a health and biomedical research foundation, not the specified company Health Services Research & Pharmacoepi Unit. No product/service information for the specified company is available in the provided source.

Differentiator

Problem solved

Functional benefit

Brands

• Fisabio Public Health: Public health research division managed by Fisabio
• D.S. managed by Fisabio

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core and major.

• Generalitat Valenciana (Conselleria de Sanitat)coreStrategic or Co-development PartnerThe unit operates under the umbrella of Fundació Fisabio, which is directly managed by the Valencian Regional Government's health authority (Conselleria de Sanitat). This institutional relationship provides the foundational framework for all research activities.
• Universitat Jaume ImajorStrategic or Co-development PartnerCollaborative research partner in AI integration in nursing research, including joint publication of a decalogue for incorporating generative AI in care research.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• IMIM (Hospital del Mar Medical Research Institute): Hospital del Mar Medical Research Institute in Barcelona. Comparable non-profit biomedical research institute conducting epidemiology, clinical research, and public health studies with similar public funding model.
• IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer): Biomedical research institute affiliated with Hospital Clínic Barcelona. Highly comparable as a Spanish non-profit biomedical research institute conducting clinical trials, epidemiological studies, and translational health research with EU and national public funding.
• ISGlobal (Barcelona Institute for Global Health): Public research institute in Barcelona focused on global public health, epidemiology, and clinical research. Directly comparable as a Spanish non-profit research foundation conducting public health, pharmacoepidemiology, and clinical trials with international EU funding.
• IIS La Fe (Instituto de Investigación Sanitaria La Fe): La Fe University Hospital research institute in Valencia. Highly comparable Valencian regional research institute conducting clinical trials, pharmacoepidemiology, and public health research under the same regional health system context.
• VHIR (Vall d'Hebron Institut de Recerca): Vall d'Hebron University Hospital research institute in Barcelona. Directly comparable Spanish public hospital-affiliated biomedical research institute running large clinical trial pipelines and translational research under public funding.
• IDIBELL (Institut d'Investigació Biomèdica de Bellvitge): Bellvitge biomedical research institute in Catalonia. Comparable in mission and structure: non-profit biomedical research foundation conducting clinical trials, public health research, and pharmacoepidemiology with regional and EU public funding.
• IBIMA Plataforma BIONAND: Malaga biomedical research institute. Comparable Spanish non-profit biomedical research foundation conducting clinical trials, epidemiology, and translational research with public institutional funding.
• IRYCIS (Instituto Ramón y Cajal de Investigación Sanitaria): Ramón y Cajal Hospital research institute in Madrid. Comparable Spanish public hospital-affiliated research institute conducting clinical trials, public health research, and pharmacoepidemiology with public institutional funding.

Broad incumbents

• Instituto de Salud Carlos III (ISCIII): Spain's national public health and biomedical research funding and coordination body. Direct comparator as a publicly funded Spanish health research institution that channels national R&D funding and operates the research institute network of which Fisabio is a node.
• CIBER (Centro de Investigación Biomédica en Red): Spain's national thematic biomedical research network under ISCIII. Comparable as the umbrella network coordinating Spanish public biomedical research areas (epidemiology, public health, etc.) where Fisabio-affiliated groups participate.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/health-services-research-pharmacoepi-unit

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Health Services Research & Pharmacoepi Unit